Table 2 |
|||
|
Determinants of maintaining treatment unchanged |
|||
|
Odds ratio |
95% confidence interval |
P value |
|
|
|
|||
|
Patient's global assessment of disease activity |
0.15 |
0.11 to 0.21 |
< 0.0001 |
|
Erythrocyte sedimentation rate |
0.49 |
0.37 to 0.65 |
< 0.0001 |
|
Number of tender joints |
0.34 |
0.23 to 0.49 |
< 0.0001 |
|
Number of swollen joints |
0.004 |
0.003 to 0.005 |
< 0.0001 |
|
Interaction (number of tender joints × number of swollen joints) |
2.06 |
1.51 to 2.82 |
< 0.0001 |
|
|
|||
|
Determined using multivariate logistic regression, n = 7,224. Overall, all 28-joint disease activity score (DAS28) components are significant determinants of the decision to maintain treatment unchanged. All variables are transformed according to the DAS28 formula. |
|||
|
de Bandt et al. Arthritis Research & Therapy 2009 11:R157 doi:10.1186/ar2836 |
|||